Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Sessa

Showing results (11-20 of 570) with videos related to

Pageof 57
Sort By:
The Lancet. Oncology|February 3, 2007
Nitric oxide synthase inhibition and cancerWilliam C Sessa
Arteriosclerosis, Thrombosis, and Vascular Biology|October 21, 2011
MicroRNA regulation of cardiovascular functionsWilliam C Sessa
Journal of Thrombosis and Haemostasis : JTH|July 28, 2009
Molecular control of blood flow and angiogenesis: role of nitric oxideW C Sessa
Circulation Research|October 16, 2012
A new approach to weight loss: just activate endothelial NO synthase!William C Sessa
Cell Metabolism|August 3, 2010
A new way to lower blood pressure: pass the chili peppers please!William C Sessa
Expert Opinion on Investigational Drugs|July 1, 1997
DNA minor groove binding ligands: a new class of anticancer agentsM D'Incalci, C Sessa
Acta Oncologica (Stockholm, Sweden)|January 1, 1989
Informing patients about phase I trials--how should it be done?Y Willems, C Sessa
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 10, 2010
Trabectedin in ovarian cancer: could we expect more?C Sessa, M D'Incalci
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 17, 2000
Current issues in phase I trials: new study designs and informed consent proceduresF Cavalli, C Sessa
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1990
Who benefits from phase I studies?C Sessa, F Cavalli
Pageof 57

Showing results (11-20 of 570) with videos related to

Sort By:
Pageof 57
The Lancet. Oncology|February 3, 2007
Nitric oxide synthase inhibition and cancerWilliam C Sessa
Arteriosclerosis, Thrombosis, and Vascular Biology|October 21, 2011
MicroRNA regulation of cardiovascular functionsWilliam C Sessa
Journal of Thrombosis and Haemostasis : JTH|July 28, 2009
Molecular control of blood flow and angiogenesis: role of nitric oxideW C Sessa
Circulation Research|October 16, 2012
A new approach to weight loss: just activate endothelial NO synthase!William C Sessa
Cell Metabolism|August 3, 2010
A new way to lower blood pressure: pass the chili peppers please!William C Sessa
Expert Opinion on Investigational Drugs|July 1, 1997
DNA minor groove binding ligands: a new class of anticancer agentsM D'Incalci, C Sessa
Acta Oncologica (Stockholm, Sweden)|January 1, 1989
Informing patients about phase I trials--how should it be done?Y Willems, C Sessa
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 10, 2010
Trabectedin in ovarian cancer: could we expect more?C Sessa, M D'Incalci
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 17, 2000
Current issues in phase I trials: new study designs and informed consent proceduresF Cavalli, C Sessa
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1990
Who benefits from phase I studies?C Sessa, F Cavalli
Pageof 57